Dr. Jon J. Vermeire

Yale University, USA

Email: jon.vermeire@yale.edu

Qualifications

2006  Ph.D., University of Wisconsin, Comparative Biomedical Sciences

2001  B.Sc., Illinois State University, Biological Sciences

Publications (selected)

1. Cho Y, Crichlow GV, Vermeire JJ, Leng L, Du X, Hodsdon ME, Bucala R, Cappello M, Gross M, Gaeta F, Johnson K & Lolis EJ. 2010. Allosteric inhibition of macrophage migration inhibitory factor revealed by ibudilast. Proceedings of the National Academy of Sciences, Jun 22; 107(25):11313-8.
2. Cho Y, Vermeire JJ (co-first author), Merkel JS, Leng L, Du X, Bucala R, Cappello M & Lolis E. 2011. Repositioning drugs by screening approved small molecules for the treatment of hookworm infection. Chemistry & Biology, Sep 23; 18(9):1089-101.
3. Vermeire JJ, Lantz LD & Caffrey CR. 2012. Cure of hookworm infection with a cysteine protease inhibitor. PLoS Neglected Tropical Diseases, Jul; 6(7):e1680.
4. Treger RS, Cook AG, Rai G, Maloney DJ, Simeonov A, Jadhav A, Thomas CJ, Williams DL, Cappello M & Vermeire JJ. 2012. Oxadiazole 2-oxides are toxic to the human hookworm,Ancylostoma ceylanicum, however glutathione reductase is not the primary target. International Journal for Parasitology: Drugs and Drug Resistance, Dec 1; 2:171-77
5. Mott BT, Cheng KCC, Guha R, Kommer VP, Williams DL, Vermeire JJ, Cappello M, Maloney DJ, Rai G, Jadhav A, Simeonov, Inglese J, Posner GH & Thomas CJ. 2012. A furoxan–amodiaquine hybrid as a potential therapeutic for three parasitic diseases. MedChemComm, Dec; 3(12):1505-11.